Risultati scientifici

1-benzyl-1,4-diazepane reduces the efflux of resistance-nodulation-cell division pumps inEscherichia coli

Anno: 2020

Autori: Casalone E., Vignolini T., Bracono L., Gardini L., Capitanio M., Pavone F.S., Dei S., Teodori E.

Affiliazione autori: Department of Biology, University of Florence, Via Madonna del Piano 6, 50019 Sesto Fiorentino, Italy; LENS – European Laboratory for Non-linear Spectroscopy, Via Nello Carrara 1, 50019 Sesto Fiorentino, Italy; Department of Neuroscience, Psychology, Drug Research and Child Health (NEUROFARBA), Via U. Schiff, 6 – 50019 Sesto Fiorentino, Italy; 4ational Institute of Optics–National Research Council, Largo Fermi 6, 50125 Florence, Italy; Department of Physics and Astronomy, University of Florence, Via Sansone 1, 50019 Sesto Fiorentino, Italy.

Abstract: Aim: To investigate the action mechanism of 1-benzyl-1,4-diazepane (1-BD) as efflux pump inhibitor (EPI) in Escherichia coli mutants: ΔacrAB or overexpressing AcrAB and AcrEF efflux pumps. Materials & methods: Effect of 1-BD on: antibiotic potentiation, by microdilution method; membrane functionality, by fluorimetric assays; ethidium bromide accumulation, by fluorometric real-time efflux assay; AcrB expression, by quantitative photoactivated localization microscopy. Results: 1-BD decreases the minimal inhibitory concentration of levofloxacin and other antibiotics and increase ethidium bromide accumulation in E. coli overexpressing efflux pumps but not in the ΔacrAB strain. 1-BD increases membranes permeability, without sensibly affecting inner membrane polarity and decreases acrAB transcription. Conclusion: 1-BD acts as an EPI in E. coli with a mixed mechanism, different from that of major reference EPIs.


Volume: 14 (11)      Da Pagina: 987  A: 999

Parole chiavi: Multidrug resistance; MDR; E. coli; efflux-pump inhibitor; EPI; levofloxacin potentiation; membrane permeability; AcrAB expression
DOI: 10.2217/fmb-2019-0296

Link per visualizzare la scheda su IsiWeb: Clicca qui

This site uses cookies. If you decide to continue browsing we consider that you accept their use. For more information about cookies and how to delete them please read our Info Policy on cookies use.
Read more